Advanced metastatic prostate cancer can now be treated with precision therapy. Olaparib, a precision drug inhibits poly (ADP-ribose) polymerase (PARP) protein. Treating with Olaparib delays disease progression and time to pain progression, and prolongs survival of patients with advanced, metastatic prostate cancer.
from Medindia Health News https://ift.tt/2o6EMq6
No comments:
Post a Comment